In short
This article examines several clinical trials investigating the use of influenza vaccines containing the Influenza Virus A/Darwin/9/2021 San-010 (H3N2) strain. These studies aim to evaluate the safety, efficacy, and immune responses generated by various influenza vaccine formulations in different populations and administration scenarios. The trials cover topics such as combination with other vaccines, timing of administration, and comparisons between vaccine types.
At a glance
- Vaccine Types
- Quadrivalent influenza vaccines containing Influenza Virus A/Darwin/9/2021 San-010 (H3N2)
- Study Populations
- Adults aged 18-65, older adults aged 60-85, and individuals aged 65 and over
- Administration Methods
- Intramuscular injection, intranasal spray
- Combination Studies
- Co-administration with COVID-19 vaccines, comparison of adjuvanted and unadjuvanted flu vaccines
- Primary Outcomes
- Antibody responses, seroconversion rates, T cell responses
- Secondary Outcomes
- Safety and reactogenicity, longevity of immune responses, cellular immunity
- Follow-up Periods
- Ranging from 28 days to 6 months post-vaccination
- Special Considerations
- Timing of vaccination, effects on mucosal immunity, comparison of different vaccine types
What is INFLUENZA VIRUS A/DARWIN/9/2021 SAN-010 (H3N2)?
INFLUENZA VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) is a component of the seasonal influenza (flu) vaccine. It is a specific strain of the influenza virus that has been selected for inclusion in the current season's flu vaccine. This strain is also known as Influenza virus A/Darwin/9/2021 (H3N2)-like strain or A/Darwin/9/2021, SAN-010.
How does the vaccine work?
The vaccine works by introducing a small, inactivated portion of the influenza virus into your body. This stimulates your immune system to produce antibodies against the virus. If you're later exposed to the actual flu virus, your body will recognize it and be better prepared to fight it off, potentially preventing illness or reducing its severity.
What is it used for?
This vaccine component is used as part of the seasonal flu vaccine to protect against influenza A (H3N2) viruses. It's typically included in quadrivalent (four-strain) flu vaccines, which offer protection against four different flu viruses that are expected to circulate during the flu season.
How is it administered?
The vaccine containing this strain is usually administered as an injection, typically in the upper arm. Depending on the specific vaccine product, it may be given as:
- An intramuscular injection (into the muscle)
- A subcutaneous injection (under the skin)
- An intranasal spray (in some live attenuated flu vaccines)
The most common method is intramuscular injection. The dose is typically 0.5 ml for adults.
How effective is it?
The effectiveness of flu vaccines can vary from year to year, depending on how well the vaccine strains match the circulating viruses. Researchers are constantly studying the effectiveness of flu vaccines, including this specific strain. Some studies are looking at factors that might influence vaccine effectiveness, such as the time of day the vaccine is administered.
What are the potential side effects?
Most people who receive flu vaccines experience mild side effects, if any. Common side effects may include:
- Soreness, redness, or swelling at the injection site
- Low-grade fever
- Mild aches
Serious allergic reactions are rare but can occur. If you experience difficulty breathing, rapid heartbeat, dizziness, or severe swelling after receiving the vaccine, seek medical attention immediately.
Who should not receive this vaccine?
While the flu vaccine is recommended for most people, some individuals should not receive it or should consult with their healthcare provider first. These include:
- People with severe, life-threatening allergies to any component of the vaccine, including egg proteins
- Infants younger than 6 months old
- People who have had a severe allergic reaction to a flu vaccine in the past
- People who are currently feeling moderately or severely ill
Always consult with your healthcare provider to determine if the flu vaccine is appropriate for you.
Current research and future directions
Ongoing research is exploring various aspects of flu vaccines, including the INFLUENZA VIRUS A/DARWIN/9/2021 SAN-010 (H3N2) strain. Some current areas of study include:
- Optimizing vaccine administration timing to enhance immune response
- Investigating the effects of co-administering flu vaccines with COVID-19 vaccines
- Studying the immune responses in different age groups, including older adults
- Exploring the use of adjuvants (substances added to vaccines to boost immune response)
These studies aim to improve the effectiveness of flu vaccines and our understanding of how they work in different populations.